RNU6-1103P

Q-omics provides the consensus-scored RNU6-1103P profile across patient tissues and cancer cell-line models. RNU6-1103P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, RNU6-1103P RNA expression shows 6,429 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight HNSC, and ESCA as cancer lineages where RNU6-1103P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RNU6-1103P survival associations across molecular data types. RNU6-1103P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-1103P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	HNSC (36)	view →

This table ranks reproducible RNU6-1103P RNA expression–survival associations across cancer types. High RNU6-1103P expression shows unfavorable associations in HNSC. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .007). Together, the overview and detailed table identify HNSC as the clearest survival context for RNU6-1103P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.179	0.628	.007	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

RNU6-1103P-HNSC (DFS)

Explore this curve interactively →